Impulse (Qingdao) Health Tech Co.,Ltd. announced a private placement of not more than 36,000,000 A shares with a par value of CNY 1 each for gross proceeds of not more than CNY 400,000,000 on October 24, 2022. The transaction will include participation from total of not more than 35 special investors. The pricing base date is the first day of the issue period, and the issue price is not less than 80% of the average price of the company's stocks 20 trading days before the first day of the issue period.

The transaction has been approved at the fourth meeting of the third board of directors in 2022 held by the company and are subject to the approval of the company's shareholders meeting and the China Securities Regulatory Commission. The resolution of this issuance is valid for 12 months from the date of deliberation and approval by the company's shareholders meeting. The lock-up period for securities to be issued is 6 months.